ArticleNeuropharmacology2025

Female Syrian hamster analyses of bremelanotide, a US FDA approved drug for the treatment of female hypoactive sexual desire disorder.

Johnathan M Borland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.